1 / 27

Why Low-Temperature?

Why Low-Temperature?. A frozen bubble created at -9F by Angela Kelly using homemade bubble solution near her home in Arlington, Washington. Sterilization Methods. FDA 510K – Sterilization Guidance Timeline. Evolution of Submission Process Driven by Technological Innovation.

tea
Download Presentation

Why Low-Temperature?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Why Low-Temperature? A frozen bubble created at -9F by Angela Kelly using homemade bubble solution near her home in Arlington, Washington.

  2. Sterilization Methods

  3. FDA 510K – Sterilization Guidance Timeline Evolution of Submission Process Driven by Technological Innovation Medical Device Amendments to Food, Drug and Cosmetic Act of 1997 *1 Addition of novel non-traditional category When to submit a 510K for a change to an existing device Food, Drug and Cosmetic Act - Section 510K Pre Market Notification Clarification on traditional and non-traditional sterilization methods *1 Clinton, William J. (21 November 1997). "Statement on Signing the Food and Drug Administration Modernization Act of 1997

  4. FDA 2008 - Recommended Review Routing Early Consultation with FDA: Key to QS Inspection Success http://bit.ly/Sterility-Info-for-510k INCB = Infection Control Devices Branch

  5. # Test Name # Cycles # Of Samples Notes Required Optional 1 Residual 2X 5 samples Run with CytoTox test R 2 CytoTox 2X 5 samples Run with residual test R 3 Animal testing 2X 5 samples Only if CytoTox fails O 4 Physical QC 2X 5-10% of load Verify product & packaging functional after 2X sterilization R 5 Accelerated Aging 2X Amount product in one shipping carton Run ASTM “Shake & Bake” test immediately after R 6 ASTM Shake 1X Amount of product in one shipping carton Verify package integrity R 7 % Efficiency of Recovery 1X 5 samples minimum non sterile product Validate extraction method for the Bioburden test method R 8 Product Bioburden 3X 10 samples each lot Run three different lots, non sterile product R 9 Product Bioburden versus BI/PCD 1X 20 samples – 10 TSB / 10- FTM Compare product Bioburden against BI/PCD O 10 PQ Micro per ISO 14937 Full load with packaging -         3 ½ cycles -         1 sublethal cycle -         3 full production runs R 11 BI Titer Perform on every BI lot Initial validation lot, all production lots O Recommended & Required Testing for FDA Submissions

  6. Medical Device Approval Process Identifying the Right Offices within FDA Critical to Success

  7. SAL and Overkill Sterility Assurance Level (SAL) Overkill Cycle • Microbiology term to describe the probability of a single unit being non-sterile after it has been subjected to the sterilization process • SALs can be used to describe the microbial population that was destroyed by the sterilization process. Each log reduction (10−1) represents a 90% reduction in microbial population. • A 10−6 SAL (12-log reduction) will reduce a population from a million organisms (106) to very close to zero, theoretically. 3MTM Attest™ Products Sterile U Network - T U T O R I A L S Living Organisms for Sterility Assurance— Biological Indicators

  8. ISO 14937:2009 http://bit.ly/ISO14937

  9. Other ISO Standards ISO 11737-1: 2006 – Sterilization of medical devices – Microbiological methods – Part 1: Determination of a population of microorganisms on products ISO 11737-2: 2009 – Sterilization of medical devices – Microbiological methods – Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process

  10. Low-Temp Steam & Formaldehyde EN 14180:2003 - Sterilizers for medical purposes. Low temperature steam and formaldehyde sterilizers. Requirements and testing BS EN ISO 25424:2011 - Sterilization of medical devices. Low temperature steam and formaldehyde. Requirements for development, validation and routine control of a sterilization process for medical devices BS EN ISO 11138-5:2006 - Sterilization of health care products. Biological indicatorsBiological indicators for low-temperature steam and formaldehyde sterilization processes

  11. Microbial Load Determination(ISO 11737-1:2006) Packaged Product (non-sterile) Membrane Filtration Transfer Sample Immersion In Media Extraction of Bioburden Aerobic Bacteria Anaerobic Bacteria Fungal Bioburden Enumeration (sterile container) (shaker)

  12. Sterility Test(ISO 11737-2:2009) Sample Immersion In Sterile Media Incubation (14 Days) Packaged Product (non-sterile) Pass Fail

  13. Cycle Development • Processes developed are specific to product/packaging combination. • BIs placed in most difficult to kill location. • Product, load configuration and packaging fixed. Bioburden is monitored and controlled. • No surviving microorganisms after exposure to a reduced level of treatment (as per AAMI/ISO 14937). • Demonstration that BI is highly resistant to the sterilizing agent relative to the product bioburden (as per AAMI/ISO 14937).

  14. Process Challenge Device http://bit.ly/Process-Challenge-Devices

  15. Incubator Validation What’s different?

  16. Chemical Indicators Warnings: These are not to be used instead of BIs Be careful how you store these

  17. H202 Cycle Safety Margins – 4 Injection Dose Response Safety Half-Cycle Safety

  18. Sterilization Validation Steps Material Compatibility Cycle Development (i.e., fractional cycles) Calibration & IQ 1 Fractional or Sub-lethal Cycle & 3 Half-Cycles 3 Full-Cycles

  19. Incubation Reduction Study http://bit.ly/Incubation-Reduction Biological Indicator (BI) With Spores Incubation ≤80 BIs No Growth (3 lots min. of 100) • ≥30 BIs Fractional Cycle BI In Sterile Media Growth

  20. UV Light http://bit.ly/Honle-UV Booth 760 – Honle UV America Inc. http://bit.ly/Lesco-UV Booth 1655 – American Ulraviolet

  21. EtO in a Bag http://bit.ly/Anprolene Booth 3092 – Anderson Products

  22. NO2 Sterilization Overview

  23. Noxilizer Booth #675 MDM West Michael Valentine VP, NA Sales

  24. H2O2 Sterilization Overview

  25. H2O2 Sterilizers VHP – Vapor Hydrogen Peroxide Gas Plasma http://bit.ly/Steris-Amsco Booth 2109 – Steris Isomedix

  26. Q&A

  27. Need help with process validation?

More Related